Point-Of-Care Molecular Diagnostics Market Growth Is Accelerating As Industry Transformation Continues
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The point-of-care molecular diagnostics sector is experiencing rapid expansion, driven by technological advancements and an increasing need for swift diagnostic solutions. This market’s evolution reflects growing healthcare demands and innovations aimed at improving early disease detection and patient management. Let’s explore the current market size, key drivers, major players, and emerging trends shaping this important healthcare segment.
Point-of-Care Molecular Diagnostics Market Size and Growth Outlook
The point-of-care molecular diagnostics market has witnessed impressive growth recently, with its size expected to rise from $3.98 billion in 2025 to $4.58 billion in 2026, representing a compound annual growth rate (CAGR) of 15.0%. Looking ahead, the market is projected to expand further, reaching $7.91 billion by 2030 at a CAGR of 14.7%. Factors contributing to this surge include the growing adoption of home-based molecular testing, increased investment in rapid diagnostic infrastructure, broader use in respiratory and oncology testing, greater integration of cloud-based diagnostic platforms, and a heightened focus on early disease detection. Key trends anticipated during this period encompass the widespread adoption of rapid molecular testing solutions, the rise of decentralized diagnostics, enhanced automated sample processing, expansion of syndromic testing panels, and efforts to reduce turnaround times.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp
Primary Factors Contributing to Point-of-Care Molecular Diagnostics Market Growth
The rising incidence of infectious and respiratory diseases is a major factor propelling the growth of the point-of-care molecular diagnostics market. Respiratory infections caused by viruses or bacteria affect the respiratory tract and spread through coughing, sneezing, or direct contact. These illnesses often require a combination of inhalers, oral and intravenous medications, and point-of-care molecular diagnostic tests to provide effective treatment.
To illustrate, data from the UK Health Security Agency in June 2024 showed a sharp increase in influenza-related critical care admissions within NHS trusts in England. Between week 40 of 2022 and week 15 of 2023, there were 1,681 such admissions reported across 108 trusts, compared to 182 admissions across 114 trusts in the previous season, which rose to 316 by week 39 of 2022. This substantial rise in infectious and respiratory cases highlights the urgent need for timely diagnostic testing, supporting market growth.
Access The Complete Point-Of-Care Molecular Diagnostics Market Report:
Detailed Breakdown of the Point-of-Care Molecular Diagnostics Market Segments
This market is segmented in the report based on product types, applications, and end-users. The product category includes Assays and Kits, as well as Instruments and Analyzers. Applications cover Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), and Bloodstream and Sepsis-Related Infections. End-users comprise Decentralized Labs, Hospitals, Home Care, and Assisted Living Healthcare Facilities.
Within Assays and Kits, subsegments feature Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, and Reagents and Consumables. Instruments and Analyzers include microfluidic devices and point-of-care analyzers, emphasizing the diversity of available technologies.
Innovative Advances Transforming the Point-of-Care Molecular Diagnostics Industry
Leading market players are focused on enhancing their portfolios by adopting cutting-edge technologies, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, and DNA microarrays. These innovations aim to accelerate test result times while minimizing costs.
For example, in May 2023, US-based Sensible Diagnostics unveiled a 10-minute point-of-care PCR system. Drawing from Curative’s extensive pandemic testing experience—having conducted over two million molecular point-of-care COVID-19 tests—this platform delivers rapid results, demonstrating the sector’s drive towards improving efficiency and accessibility.
Key Players Shaping the Point-of-Care Molecular Diagnostics Market
Several major companies maintain a significant presence in this market, including Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, and Seegene Inc. These firms play a vital role in driving innovation and expanding market reach.
Regional Market Leaders and Growth Prospects
In 2025, North America accounted for the largest share of the point-of-care molecular diagnostics market. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast period. The market analysis includes comprehensive coverage of regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad perspective on global market dynamics.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
